Mangoceuticals (MGRX) Return on Assets (2023 - 2026)

Mangoceuticals has disclosed Return on Assets across 4 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Assets for Q1 2026 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Assets came in at 0.01% for Q1 2026 at Mangoceuticals, up from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.01% in Q4 2024 to a low of 0.13% in Q1 2024.
• The 4-year median for Return on Assets is 0.01% (2024), against an average of 0.03%.
• Peak annual rise in Return on Assets reached 13 bps in 2025, while the deepest fall reached 1 bps in 2025.
• Mangoceuticals' Return on Assets stood at 0.07% in 2023, then jumped by 92 bps to 0.01% in 2024, then tumbled by 119 bps to 0.01% in 2025, then advanced by 1 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.